gastrodin has been researched along with Chronic Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, AO; He, J; Liu, Y; Muhammed, FK; Shi, C; Zheng, B | 1 |
| Li, Y; Zhang, Z | 1 |
2 other study(ies) available for gastrodin and Chronic Illness
| Article | Year |
|---|---|
Gastrodin alleviates bone damage by modulating protein expression and tissue redox state.
Topics: Animals; Apoptosis; Benzyl Alcohols; Bone and Bones; Cancellous Bone; Cell Line; Cell Proliferation; Chronic Disease; Femur; Fluorides; Fluorosis, Dental; Glucosides; Humans; Male; Oxidation-Reduction; Oxidative Stress; Proteins; Rats, Wistar | 2020 |
Gastrodin improves cognitive dysfunction and decreases oxidative stress in vascular dementia rats induced by chronic ischemia.
Topics: Alcohol Dehydrogenase; Animals; Antioxidants; Apoptosis; Behavior, Animal; Benzyl Alcohols; Brain; Brain Ischemia; Cell Line, Tumor; Cerebrovascular Circulation; Chronic Disease; Cognition; Dementia, Vascular; Disease Models, Animal; Dose-Response Relationship, Drug; Glucosides; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Maze Learning; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Sulfhydryl Compounds; Time Factors | 2015 |